000423 Stock Overview
Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Dong-E-E-Jiao Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥56.59 |
| 52 Week High | CN¥72.91 |
| 52 Week Low | CN¥44.62 |
| Beta | 0.69 |
| 11 Month Change | -4.25% |
| 3 Month Change | 16.68% |
| 1 Year Change | 12.77% |
| 33 Year Change | 38.36% |
| 5 Year Change | 69.84% |
| Change since IPO | -1.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 000423 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.4% | -1.5% | -2.1% |
| 1Y | 12.8% | -9.4% | 2.8% |
Return vs Industry: 000423 exceeded the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 000423 exceeded the CN Market which returned 2.8% over the past year.
Price Volatility
| 000423 volatility | |
|---|---|
| 000423 Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 000423 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000423's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | 3,678 | Jie Cheng | www.dongeejiao.com |
Dong-E-E-Jiao Co.,Ltd. research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods. The company was founded in 1952 and is based in Liaocheng, China.
Dong-E-E-Jiao Co.,Ltd. Fundamentals Summary
| 000423 fundamental statistics | |
|---|---|
| Market cap | CN¥36.36b |
| Earnings (TTM) | CN¥1.52b |
| Revenue (TTM) | CN¥5.62b |
23.9x
P/E Ratio6.5x
P/S RatioIs 000423 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000423 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.62b |
| Cost of Revenue | CN¥1.52b |
| Gross Profit | CN¥4.10b |
| Other Expenses | CN¥2.58b |
| Earnings | CN¥1.52b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.36 |
| Gross Margin | 72.92% |
| Net Profit Margin | 27.05% |
| Debt/Equity Ratio | 0% |
How did 000423 perform over the long term?
See historical performance and comparison